Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone

被引:69
作者
Depenbusch, M [1 ]
von Eckardstein, S [1 ]
Simoni, M [1 ]
Nieschlag, E [1 ]
机构
[1] Univ Munster, Inst Reprod Med, D-48149 Munster, Germany
关键词
D O I
10.1530/eje.0.1470617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: It is generally accepted that both gonadotropins LH and FSH are necessary for initiation and maintenance of spermatogenesis. We investigated the relative importance of FSH for the maintenance of spermatogenesis in hypogonadotropic men. Subjects and methods: 13 patients with gonadotropin deficiency due to idiopathic hypogonadotropic hypogonadism (EM), Kallmann syndrome or pituitary insufficiency were analyzed retrospectively. They had been treated with gonadotropin-releasing hormone (GnRH) (n = 1) or human chorionic gonadotropin/human menopausal gonadotropin (hCG/hMG) (n = 12) for induction of spermatogenesis. After successful induction of spermatogenesis they were treated with hCG alone for maintenance of secondary sex characteristics and in order to check whether sperm production could be maintained by hCG alone. Serum LH, FSH and testosterone levels, semen parameters and testicular volume were determined every three to six months. Results: After spermatogenesis had been successfully induced by treatment with GnRH or hCG/hMG, hCG treatment alone continued for 3-24 months. After 12 months under hCG alone, sperm counts decreased gradually but remained present in all patients except one who became azoospermic. Testicular volume decreased only slightly and reached 87% of the volume achieved with hCG/hMG. During treatment with hCG alone, FSH and LH levels were suppressed to below the detection limit of the assay. Conclusion: Once spermatogenesis is induced in patients with secondary hypogonadism by GnRH or hCG/hMG treatment, it can be maintained in most of the patients qualitatively by hCG alone, in the absence of FSH, for extended periods. However, the decreasing sperm counts indicate that FSH is essential for maintenance of quantitatively normal spermatogenesis.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 41 条
[1]  
[Anonymous], 1987, WHO LAB MANUAL EXAMI
[2]  
[Anonymous], 1999, WHO LAB MANUAL EXAMI, V4th
[3]  
[Anonymous], 1992, WHO LAB MANUAL EXAMI
[4]   EXOGENOUSLY ADMINISTERED TESTOSTERONE MAINTAINS SPERMATOGENESIS QUANTITATIVELY IN ADULT-RATS ACTIVELY IMMUNIZED AGAINST GONADOTROPIN-RELEASING-HORMONE [J].
AWONIYI, CA ;
ZIRKIN, BR ;
CHANDRASHEKAR, V ;
SCHLAFF, WD .
ENDOCRINOLOGY, 1992, 130 (06) :3283-3288
[5]  
BAUER GF, 1996, LEYDIG CELL, P629
[6]   Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone [J].
Behre, HM ;
Kliesch, S ;
Lemcke, B ;
von Eckardstein, S ;
Nieschlag, E .
HUMAN REPRODUCTION, 2001, 16 (12) :2570-2577
[7]  
Behre HM, 1995, INT J ANDROL, V18, P27
[8]  
Behre HM, 2000, ANDROLOGY MALE REPRO, P89
[9]  
Behre HM, 2000, ANDROLOGY MALE REPRO, P125
[10]   Pulsatile GnRH or human chorionic gonadotropin human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism:: a review of 42 cases [J].
Büchter, D ;
Behre, HM ;
Kliesch, S ;
Nieschlag, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (03) :298-303